检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

A phase II study of hyper-CVAD with sequential blinatumomab (Blina), with or without inotuzumab ozogamicin (INO), in adults with newly diagnosed B-cell acute lymphoblastic leukemia (ALL).

Nicholas James Short,Hagop M. Kantarjian,Farhad Ravandi,Musa Yilmaz,Tapan M. Kadia,Philip A. Thompson,Marina Konopleva,Alessandra Ferrajoli,Nitin Jain,Koji Sasaki,Yesid Alvarado Valero,Gautam Borthakur,Courtney Denton Dinardo,Maro Ohanian,Walid Macaron,Rebecca Garris, Min Zhao,Monica Kwari,Christopher Loiselle,Elias Jabbour

JOURNAL OF CLINICAL ONCOLOGY（2022）

引用 3|浏览3
暂无评分
关键词
inotuzumab ozogamicin,lymphoblastic leukemia,sequential blinatumomab,hyper-cvad,b-cell
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要